Celldex Therapeutics (CLDX) Goodwill (2010 - 2017)

Celldex Therapeutics' Goodwill history runs 8 years deep, the most recent figure standing at $91.0 million for Q4 2017.

• On a quarterly basis, Goodwill changed 0.0% year-over-year to $91.0 million in Q4 2017; TTM through Dec 2017 was $91.0 million, a 0.0% change from a year earlier, with the FY2017 full-year figure at $91.0 million, changed 0.0% from the prior year.
• Goodwill steadied at $91.0 million in Q4 2017 per CLDX's latest filing, from $91.0 million in the prior quarter.
• Across five years, Goodwill topped out at $91.0 million in Q4 2016 and bottomed at $9.0 million in Q1 2013.
• The 5-year median for Goodwill is $9.0 million (2013), against an average of $29.5 million.
• Across the five-year window, Goodwill changed 0.0% in 2013 and surged 914.79% in 2016, its largest moves.
• Year by year, Goodwill stood at $9.0 million in 2013, then changed by 0.0% to $9.0 million in 2014, then changed by 0.0% to $9.0 million in 2015, then jumped by 914.79% to $91.0 million in 2016, then changed by 0.0% to $91.0 million in 2017.
• Per Business Quant, the three latest CLDX Goodwill figures stand at $91.0 million (Q4 2017), $91.0 million (Q3 2017), and $91.0 million (Q2 2017).